Elanco Animal Health (ELAN) Operating Expenses (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Operating Expenses came in at $478.0 million in Q1 2026, up 9.89% year-on-year from $435.0 million in Q1 2025, and up 10.9% quarter-over-quarter from $431.0 million in Q4 2025.
Elanco Animal Health (ELAN) Operating Expenses (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Operating Expenses across 10 years of filings, most recently posting $478.0 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $478.0 million, up 9.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (down 42.34% YoY), and the FY2025 annual result was $1.8 billion, down 54.49% from the prior year.
- Operating Expenses came in at $478.0 million for Q1 2026 at Elanco Animal Health, up from $431.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $2.2 billion in Q3 2023 to a low of $431.0 million in Q4 2025.
- The 5-year median for Operating Expenses is $1.1 billion (2022), against an average of $960.2 million.
- Across the five-year window, Operating Expenses surged 102.34% in 2023 and sank 78.24% in 2024, its largest moves.
- Elanco Animal Health's Operating Expenses stood at $1.1 billion in 2022, then increased by 8.19% to $1.2 billion in 2023, then slipped by 7.83% to $1.1 billion in 2024, then tumbled by 59.76% to $431.0 million in 2025, then gained by 10.9% to $478.0 million in 2026.
- The last three Operating Expenses figures came in at $478.0 million (Q1 2026), $431.0 million (Q4 2025), and $440.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 96.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 475.11 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 71.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 478.00 Mn |
| Dec 31, 2025 | 431.00 Mn |
| Sep 30, 2025 | 440.00 Mn |
| Jun 30, 2025 | 492.00 Mn |
| Mar 31, 2025 | 435.00 Mn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 471.00 Mn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 2.17 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.07 Bn |
| Jun 30, 2022 | 1.19 Bn |
| Mar 31, 2022 | 1.15 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 1.26 Bn |
| Jun 30, 2021 | 1.52 Bn |